CN104928351A - 一种硼酸介导的聚合酶链反应检测dna中5-羟甲基胞嘧啶的方法和试剂盒 - Google Patents
一种硼酸介导的聚合酶链反应检测dna中5-羟甲基胞嘧啶的方法和试剂盒 Download PDFInfo
- Publication number
- CN104928351A CN104928351A CN201410102734.0A CN201410102734A CN104928351A CN 104928351 A CN104928351 A CN 104928351A CN 201410102734 A CN201410102734 A CN 201410102734A CN 104928351 A CN104928351 A CN 104928351A
- Authority
- CN
- China
- Prior art keywords
- dna
- boric acid
- hydroxymethyl cytosine
- 5hmc
- glucosyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 title claims abstract description 57
- 239000004327 boric acid Substances 0.000 title claims abstract description 51
- 238000000034 method Methods 0.000 title claims abstract description 51
- RYVNIFSIEDRLSJ-UHFFFAOYSA-N 5-(hydroxymethyl)cytosine Chemical compound NC=1NC(=O)N=CC=1CO RYVNIFSIEDRLSJ-UHFFFAOYSA-N 0.000 title claims abstract description 41
- 238000003752 polymerase chain reaction Methods 0.000 title claims abstract description 21
- 230000001404 mediated effect Effects 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 40
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 37
- 238000006243 chemical reaction Methods 0.000 claims abstract description 29
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 25
- 230000003321 amplification Effects 0.000 claims abstract description 23
- 238000001514 detection method Methods 0.000 claims abstract description 22
- 238000004458 analytical method Methods 0.000 claims abstract description 12
- 230000000694 effects Effects 0.000 claims abstract description 11
- 238000011160 research Methods 0.000 claims abstract description 9
- 230000008827 biological function Effects 0.000 claims abstract description 8
- 229940104302 cytosine Drugs 0.000 claims abstract description 6
- 150000002009 diols Chemical group 0.000 claims abstract description 4
- 108020004414 DNA Proteins 0.000 claims description 44
- 239000000523 sample Substances 0.000 claims description 33
- 230000008569 process Effects 0.000 claims description 27
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 25
- 238000012360 testing method Methods 0.000 claims description 24
- 239000013641 positive control Substances 0.000 claims description 17
- 230000008859 change Effects 0.000 claims description 15
- 239000012634 fragment Substances 0.000 claims description 9
- 239000013642 negative control Substances 0.000 claims description 9
- 206010028980 Neoplasm Diseases 0.000 claims description 7
- 230000014509 gene expression Effects 0.000 claims description 7
- -1 boric acid compound Chemical class 0.000 claims description 6
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 claims description 6
- 230000035131 DNA demethylation Effects 0.000 claims description 4
- 230000004543 DNA replication Effects 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 230000008672 reprogramming Effects 0.000 claims description 4
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 claims description 3
- 238000000137 annealing Methods 0.000 claims description 3
- 230000004087 circulation Effects 0.000 claims description 3
- 230000001351 cycling effect Effects 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 150000004985 diamines Chemical group 0.000 claims description 3
- 230000002068 genetic effect Effects 0.000 claims description 3
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims description 3
- SDEAGACSNFSZCU-UHFFFAOYSA-N (3-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(Cl)=C1 SDEAGACSNFSZCU-UHFFFAOYSA-N 0.000 claims description 2
- 101150036080 at gene Proteins 0.000 claims description 2
- 229940124530 sulfonamide Drugs 0.000 claims description 2
- 238000013467 fragmentation Methods 0.000 claims 2
- 238000006062 fragmentation reaction Methods 0.000 claims 2
- 108020005196 Mitochondrial DNA Proteins 0.000 claims 1
- 238000012339 Real-time fluorescence quantitative polymerase chain reaction Methods 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
- 238000012408 PCR amplification Methods 0.000 description 26
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 15
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 15
- 210000001161 mammalian embryo Anatomy 0.000 description 14
- 210000000130 stem cell Anatomy 0.000 description 14
- 108091008146 restriction endonucleases Proteins 0.000 description 11
- 238000003753 real-time PCR Methods 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 101000601724 Homo sapiens Paired box protein Pax-5 Proteins 0.000 description 6
- 102100037504 Paired box protein Pax-5 Human genes 0.000 description 6
- 239000012445 acidic reagent Substances 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 101100351019 Homo sapiens PAX5 gene Proteins 0.000 description 5
- 101150017484 PAX5 gene Proteins 0.000 description 5
- 101000889901 Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) Tetrahedral aminopeptidase Proteins 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000013595 glycosylation Effects 0.000 description 4
- 238000006206 glycosylation reaction Methods 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- 238000001353 Chip-sequencing Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102000004357 Transferases Human genes 0.000 description 3
- 108090000992 Transferases Proteins 0.000 description 3
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 3
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 3
- 125000000188 beta-D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000017858 demethylation Effects 0.000 description 3
- 238000010520 demethylation reaction Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- BLQMCTXZEMGOJM-UHFFFAOYSA-N 5-carboxycytosine Chemical compound NC=1NC(=O)N=CC=1C(O)=O BLQMCTXZEMGOJM-UHFFFAOYSA-N 0.000 description 2
- FHSISDGOVSHJRW-UHFFFAOYSA-N 5-formylcytosine Chemical compound NC1=NC(=O)NC=C1C=O FHSISDGOVSHJRW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 230000033616 DNA repair Effects 0.000 description 2
- 102100026406 G/T mismatch-specific thymine DNA glycosylase Human genes 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000004885 tandem mass spectrometry Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102100035080 BDNF/NT-3 growth factors receptor Human genes 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 108020001738 DNA Glycosylase Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102000028381 DNA glycosylase Human genes 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 101000903725 Enterobacteria phage T4 DNA beta-glucosyltransferase Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 101000596896 Homo sapiens BDNF/NT-3 growth factors receptor Proteins 0.000 description 1
- 101000653369 Homo sapiens Methylcytosine dioxygenase TET3 Proteins 0.000 description 1
- 101000928535 Homo sapiens Protein delta homolog 1 Proteins 0.000 description 1
- 101000642512 Homo sapiens Transcription factor SOX-5 Proteins 0.000 description 1
- 101000642517 Homo sapiens Transcription factor SOX-6 Proteins 0.000 description 1
- 101001074042 Homo sapiens Transcriptional activator GLI3 Proteins 0.000 description 1
- 102100030812 Methylcytosine dioxygenase TET3 Human genes 0.000 description 1
- 102100030610 Mothers against decapentaplegic homolog 5 Human genes 0.000 description 1
- 101710143113 Mothers against decapentaplegic homolog 5 Proteins 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108010035344 Thymine DNA Glycosylase Proteins 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 102100036692 Transcription factor SOX-5 Human genes 0.000 description 1
- 102100036694 Transcription factor SOX-6 Human genes 0.000 description 1
- 102100035559 Transcriptional activator GLI3 Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000033590 base-excision repair Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 238000001369 bisulfite sequencing Methods 0.000 description 1
- 125000005619 boric acid group Chemical group 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006326 desulfonation Effects 0.000 description 1
- 238000005869 desulfonation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000002503 granulosa cell Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000005096 hematological system Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 210000003519 mature b lymphocyte Anatomy 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000000449 purkinje cell Anatomy 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 229940048102 triphosphoric acid Drugs 0.000 description 1
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410102734.0A CN104928351B (zh) | 2014-03-19 | 2014-03-19 | 一种硼酸介导的聚合酶链反应检测dna中5‑羟甲基胞嘧啶的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410102734.0A CN104928351B (zh) | 2014-03-19 | 2014-03-19 | 一种硼酸介导的聚合酶链反应检测dna中5‑羟甲基胞嘧啶的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104928351A true CN104928351A (zh) | 2015-09-23 |
CN104928351B CN104928351B (zh) | 2018-04-17 |
Family
ID=54115776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410102734.0A Active CN104928351B (zh) | 2014-03-19 | 2014-03-19 | 一种硼酸介导的聚合酶链反应检测dna中5‑羟甲基胞嘧啶的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104928351B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106281309A (zh) * | 2016-08-03 | 2017-01-04 | 陕西师范大学 | 硼酸衍生物功能化荧光探针在检测5‑羟甲基胞嘧啶中的应用 |
CN106350064A (zh) * | 2016-08-30 | 2017-01-25 | 上海大学 | 利用微波加热法水热炭化造纸黑液制备水溶性荧光碳材料的方法 |
CN109182465A (zh) * | 2018-08-03 | 2019-01-11 | 中山大学 | 一种高通量核酸表观遗传修饰定量分析方法 |
CN110527708A (zh) * | 2019-07-11 | 2019-12-03 | 武汉伯远生物科技有限公司 | 一种区分dna中5-甲基化胞嘧啶和5-羟甲基化胞嘧啶的方法 |
CN113151402A (zh) * | 2021-03-10 | 2021-07-23 | 山东师范大学 | 一种检测dna羟化酶tet1的纳米传感器及其检测方法和应用 |
CN117004717A (zh) * | 2023-05-10 | 2023-11-07 | 上海鲸舟基因科技有限公司 | 一种特异性检测5hmC的方法 |
-
2014
- 2014-03-19 CN CN201410102734.0A patent/CN104928351B/zh active Active
Non-Patent Citations (2)
Title |
---|
ADAM B ROBERTSON ETAL: "Pull-down of 5-hydroxymethylcytosine DNA using JBP1-coated magnetic beads", 《NATURE PROTOCOLS》 * |
曹晶等: "糖蛋白/糖肽的分离富集方法", 《化学进展》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106281309A (zh) * | 2016-08-03 | 2017-01-04 | 陕西师范大学 | 硼酸衍生物功能化荧光探针在检测5‑羟甲基胞嘧啶中的应用 |
CN106281309B (zh) * | 2016-08-03 | 2018-07-10 | 陕西师范大学 | 硼酸衍生物功能化荧光探针在检测5-羟甲基胞嘧啶中的应用 |
CN106350064A (zh) * | 2016-08-30 | 2017-01-25 | 上海大学 | 利用微波加热法水热炭化造纸黑液制备水溶性荧光碳材料的方法 |
CN109182465A (zh) * | 2018-08-03 | 2019-01-11 | 中山大学 | 一种高通量核酸表观遗传修饰定量分析方法 |
CN110527708A (zh) * | 2019-07-11 | 2019-12-03 | 武汉伯远生物科技有限公司 | 一种区分dna中5-甲基化胞嘧啶和5-羟甲基化胞嘧啶的方法 |
CN113151402A (zh) * | 2021-03-10 | 2021-07-23 | 山东师范大学 | 一种检测dna羟化酶tet1的纳米传感器及其检测方法和应用 |
CN113151402B (zh) * | 2021-03-10 | 2022-08-02 | 山东师范大学 | 一种检测dna羟化酶tet1的纳米传感器及其检测方法和应用 |
CN117004717A (zh) * | 2023-05-10 | 2023-11-07 | 上海鲸舟基因科技有限公司 | 一种特异性检测5hmC的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104928351B (zh) | 2018-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11725249B2 (en) | Methods for identifying cancer risk | |
US10718025B2 (en) | Methods for predicting age and identifying agents that induce or inhibit premature aging | |
Gabel et al. | Disruption of DNA-methylation-dependent long gene repression in Rett syndrome | |
CN104928351A (zh) | 一种硼酸介导的聚合酶链反应检测dna中5-羟甲基胞嘧啶的方法和试剂盒 | |
Pfaffeneder et al. | The discovery of 5‐formylcytosine in embryonic stem cell DNA | |
Watanabe et al. | Estimation of age-related DNA degradation from formalin-fixed and paraffin-embedded tissue according to the extraction methods | |
Chen et al. | Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | |
CN112004942A (zh) | 利用了rna修饰的分析、诊断方法 | |
CN105986030A (zh) | 甲基化dna检测方法 | |
WO2018009696A1 (en) | Colon cancer methylation markers and uses thereof | |
WO2018009705A1 (en) | Liver cancer methylation markers and uses thereof | |
WO2018009703A1 (en) | Breast and ovarian cancer methylation markers and uses thereof | |
WO2018009702A1 (en) | Leukemia methylation markers and uses thereof | |
Pedersen et al. | High recovery of cell-free methylated DNA based on a rapid bisulfite-treatment protocol | |
Liu et al. | Multi-omic analysis of altered transcriptome and epigenetic signatures in the UV-induced DNA damage response | |
Pu et al. | XNA probe and CRISPR/Cas12a-powered flexible fluorescent and electrochemical dual-mode biosensor for sensitive detection of m6A site-specific RNA modification | |
CN109971843B (zh) | 一种单细胞转录组的测序方法 | |
Michaelson-Cohen et al. | Genome-wide de novo methylation in epithelial ovarian cancer | |
WO2017035821A1 (zh) | RNA 5mC重亚硫酸盐测序的文库构建方法及其应用 | |
CN108796039B (zh) | 一种用于dna甲基化检测的试剂盒与方法及应用 | |
Wu et al. | Innovative insights into extrachromosomal circular DNAs in gynecologic tumors and reproduction | |
Wong et al. | Genome-wide distribution of DNA methylation at single-nucleotide resolution | |
CN109913530A (zh) | 一种识别检测dna中5-羟甲基胞嘧啶和5-甲酰胞嘧啶的方法 | |
EP4242323A1 (en) | Method for producing mirna libraries for massive parallel sequencing | |
Hu et al. | Modular engineering of a hierarchical hybridization-reconfiguration-replication circuit for rapid detection of long noncoding RNA with attomolar sensitivity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190919 Address after: 250101 No. 2 Building No. 1, North Section of Gangxing Third Road, Jinan High-tech Zone, Shandong Province, Negative 107-108, 8th and 25th floors Co-patentee after: Shandong Yue Pin Education Group Co.,Ltd. Patentee after: Shandong Yuexin Inspection and Certification Group Co.,Ltd. Co-patentee after: JINAN MEASUREMENT METERING RESEARCH INSTITUTE Co.,Ltd. Address before: 100085 Beijing city Haidian District Shuangqing Road No. 18 Patentee before: Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 107-108, 8 / F, 25 / F, building 2, No.1, north section of Gangxing Third Road, Jinan City, Shandong Province Patentee after: Institute of food, drug and environmental control (Shandong) Group Co.,Ltd. Patentee after: Academy of food, drug and Environmental Sciences (Shandong) Group Co.,Ltd. Patentee after: Measurement Research Institute (Shandong) Group Co.,Ltd. Address before: 250101 No. 2 Building No. 1, North Section of Gangxing Third Road, Jinan High-tech Zone, Shandong Province, Negative 107-108, 8th and 25th floors Patentee before: Shandong Yuexin Inspection and Certification Group Co.,Ltd. Patentee before: Shandong Yue Pin Education Group Co.,Ltd. Patentee before: JINAN MEASUREMENT METERING RESEARCH INSTITUTE Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231219 Address after: 250100 Jinan City, Shandong Province, China (Shandong) Pilot Free Trade Zone Jinan Area, No. 1, North Section of Gangxing Third Road, Building 2, negative 107-108, 8th and 25th floors Patentee after: Institute of food, drug and environmental control (Shandong) Group Co.,Ltd. Address before: 107-108, 8 / F, 25 / F, building 2, No.1, north section of Gangxing Third Road, Jinan City, Shandong Province Patentee before: Institute of food, drug and environmental control (Shandong) Group Co.,Ltd. Patentee before: Academy of food, drug and Environmental Sciences (Shandong) Group Co.,Ltd. Patentee before: Measurement Research Institute (Shandong) Group Co.,Ltd. |
|
TR01 | Transfer of patent right |